Nivolumab and Ipilimumab in Melanoma Metastatic to the Brain

N Engl J Med. 2018 Nov 29;379(22):2178. doi: 10.1056/NEJMc1812500.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antibodies, Monoclonal
  • Brain
  • Humans
  • Ipilimumab*
  • Melanoma
  • Nivolumab*

Substances

  • Antibodies, Monoclonal
  • Ipilimumab
  • Nivolumab